February 25, 2017
Susztak, MD, PhD, an associate professor of medicine and genetics in the Perelman School of Medicine at the University of Pennsylvania, has received a $3 million grant from three pharmaceutical companies to study the genetic components of diabetic kidney disease, according to a press release.
The study, called TRIDENT, will collect kidney biopsy tissue, as well as blood, urine and genetic materials to create a multi-omics dataset. From these data, Susztak and colleagues will investigate molecular pathways and link them to biomarkers of rapid kidney function decline to compare against slower kidney-function decline. This study should help identify potential therapeutic targets for diabetic kidney disease.